Therapies for Children With Autism Spectrum Disorders

Evidence Table. Therapies for children with ASD (continued)
Study
Inclusion/ Exclusion Baseline
Description Intervention
Criteria/ Population Measures Outcomes
Practice wash-out period, followed Disorder or Pervasive
0.96
setting:
by placebo for 3 months; Developmental Disorder,
G1b+G2a: 4.43 ±
Academic medical
Not Otherwise Specified
0.55
center
Sequence 2: placebo for 3 • parent must agree to
P = 0.49
months, then 1 week avoid starting any other
Generalized
Intervention washout period, followed alternative therapies for
estimating
setting:
by supplement for 3 the child during the study
equation (GEE)
Clinic
months;
comparison of
Enrollment
Exclusion criteria:
treatment to
period:
Treatment: ½ to 1 capsule • significant hearing or
placebo: P = 0.91
NR
with the largest meal of vision loss
Funding: the day, increasing over • co-morbid neurological
NR
several days to 2
disorders including
Author industry capsules with each meal. phenylketonuria,
relationship Maximum dosage: